Marksans Pharma has informed that the meeting of the Board of Directors of the Company will be held on February 06, 2017, to consider and approve Unaudited Financial Results of the Company (both Standalone and Consolidated) for the Third Quarter ended on December 31, 2016 (Q3). Further, as per the Insider Trading Policy of the Company, Trading Window for dealing in Company’s shares will remain closed for the Company’s Insiders from January 25, 2017 (commencing from the time of above intimation to the Stock Exchanges) till 48 hours after the announcement of the third quarter financial results on February 06, 2017.
The above information is a part of company’s filings submitted to BSE.
